Gene · 5268
Papers2,479
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,479
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Trichostatin A ameliorates ulcerative colitis via the SERPINB5-mediated MMP9/RLN2 signaling pathway. | Pathol Res Pract | 2026 | 42735487 | PubTator, text mining | PubMed |
| Identification and validation of an alternatively spliced novel isoform of maspin that modulate genes involved in inflammatory and apoptotic pathways. | Gene | 2026 | 42731685 | PubTator, text mining | PubMed |
| PPM1B suppresses cervical carcinoma invasion by dephosphorylating MYPT1 at Thr853 and inactivating the PRMT5 epigenetic axis. | Eur J Cell Biol | 2026 | 42585950 | PubTator, text mining | PubMed |
| Diagnostic utility of p57Kip2, p53, and maspin in classifying hydatidiform moles. | Sci Rep | 2026 | 42457916 | PubTator, text mining | PubMed |
| CRISPR/Cas9-mediated miR-21 editing in high-grade urothelial carcinoma cells and its biological effects. | Mol Biol Rep | 2026 | 42319574 | PubTator, text mining | PubMed |
| Maspin Modulates Malignant Phenotypes Depending on Subcellular Localization in Pancreatic Ductal Adenocarcinoma Cell Lines. | Cancers (Basel) | 2026 | 42279399 | PubTator, text mining | PubMed |
| Emphysema Shapes a Pro-Inflammatory Immune Microenvironment in Pulmonary Adenocarcinoma: A Pilot Immune Transcriptomic Profiling Study. | Int J Mol Sci | 2026 | 42123542 | PubTator, text mining | PubMed |
| Myoepithelial cell cartography: A review of immunohistochemical markers in salivary gland neoplasms. | Histol Histopathol | 2026 | 42052808 | PubTator, text mining | PubMed |
| Correction: METTL3/YTHDF1 drives M1 macrophage polarization and aggravates ulcerative colitis progression by regulating m6A modification of SerpinB5 mRNA and FBXO32-dependent NF-κB pathway. | J Gastroenterol | 2026 | 41961123 | PubTator, text mining | PubMed |
| Molecular mechanisms and therapeutic strategies: DNA methylation in pancreatic cancer. | Cancer Biol Ther | 2026 | 41879036 | PubTator, text mining | PubMed |
| Development and validation of a ferroptosis-related gene signature for prognostic prediction and therapeutic target identification in invasive lobular carcinoma. | Transl Cancer Res | 2026 | 41815159 | PubTator, text mining | PubMed |
| Integrative analysis of the PSMA family identifies PSMA6 as an adverse prognostic biomarker promoting bladder cancer cell proliferation. | Int J Med Sci | 2026 | 41799753 | PubTator, text mining | PubMed |
| Research advances in pathogenic mechanisms and host response of mycoplasma pneumoniae pneumonia in children: a metabolomics perspective. | Front Med (Lausanne) | 2026 | 41756386 | PubTator, text mining | PubMed |
| Alteplase and Angioedema: Can Clinical Exome Sequencing Redefine the Paradigm? | Life (Basel) | 2026 | 41752838 | PubTator, text mining | PubMed |
| Multi-omics and machine learning-based profiling of severity signatures in Mycoplasma pneumoniae infection in children. | iScience | 2026 | 41732270 | PubTator, text mining | PubMed |
| Low-molecular-weight metabolites from lactic acid bacteria suppress cervical cancer progression by inhibiting EMT via the Wnt/β-catenin pathway. | Open Life Sci | 2026 | 41726556 | PubTator, text mining | PubMed |
| Engineering a multilayered micro-vascularized soft tissue graft: Integrating polyurethane composite nanofibres with co-cultures of human adipose-derived endothelial and stem cells. | Biomaterials | 2026 | 41702229 | PubTator, text mining | PubMed |
| MLANA is a potential prognostic biomarker and correlated with immune infiltration in skin cutaneous melanoma. | Clin Exp Med | 2026 | 41697477 | PubTator, text mining | PubMed |
| M5C-driven stabilization of SERPINB5 promotes cervical cancer progression and chemotherapy resistance. | Cell Death Dis | 2026 | 41673397 | PubTator, text mining | PubMed |
| WISP1 is the stromal-secreting oncoprotein via paracrine downregulation of NDRG1, KAI1, and Maspin in human bladder cancer cells. | Transl Oncol | 2026 | 41610754 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5268/papers